SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1477 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1477 ml

fresenius kabi australia pty ltd - soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: water for injections; glycerol; dl-alpha-tocopherol; egg lecithin; sodium oleate; sodium hydroxide - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; dl-alpha-tocopherol; glycerol; egg lecithin; water for injections; sodium hydroxide - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; sodium oleate; egg lecithin; glycerol; water for injections; dl-alpha-tocopherol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 ml

fresenius kabi australia pty ltd - olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: water for injections; dl-alpha-tocopherol; sodium oleate; sodium hydroxide; egg lecithin; glycerol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 986 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; water for injections; sodium hydroxide; egg lecithin; glycerol; sodium oleate - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 mL Australië - Engels - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; dl-alpha-tocopherol; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

Vamin 14 with electrolytes Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

vamin 14 with electrolytes

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; calcium gluconate monohydrate 2.24 g/l;  ; cysteine 0.42 g/l (as l-cysteine hydrochloride); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ; histidine 5.1 g/l (l-histidine);  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine hydrochloride 6.8 g/l;  ;  ;  ; magnesium sulfate heptahydrate 1.97 g/l; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; potassium chloride 3.73 g/l; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; sodium acetate trihydrate 13.6 g/l;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     calcium gluconate monohydrate 2.24 g/l   cysteine 0.42 g/l (as l-cysteine hydrochloride) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)     histidine 5.1 g/l (l-histidine)     isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine hydrochloride 6.8 g/l       magnesium sulfate heptahydrate 1.97 g/l methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       potassium chloride 3.73 g/l proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         sodium acetate trihydrate 13.6 g/l     threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)     excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Vamin 14 without electrolytes Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

vamin 14 without electrolytes

fresenius kabi new zealand limited - alanine 12 g/l;  ;  ;  ; arginine 8.4 g/l (l-arginine);  ;  ; aspartic acid 2.5 g/l (l-aspartic acid);  ;  ; cysteine 0.42 g/l (l-cysteine); glutamic acid 4.2 g/l (l-glutamic acid);  ;  ; glycine 5.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 5.1 g/l (l-histidine);  ;  ;  ; isoleucine 4.2 g/l (l-isoleucine);  ;  ;  ; leucine 5.9 g/l (l-leucine);  ;  ;  ; lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l;  ;  ; methionine 4.2 g/l (l-methionine);  ;  ; phenylalanine 5.9 g/l (l-phenylalanine);  ;  ;  ; proline 5.1 g/l (l-proline);  ; serine 3.4 g/l (l-serine);  ;  ;  ;  ; threonine 4.2 g/l (l-threonine);  ;  ;  ; tryptophan 1.4 g/l (l-tryptophan);  ; tyrosine 0.17 g/l (l-tyrosine); valine 5.5 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 12 g/l       arginine 8.4 g/l (l-arginine)     aspartic acid 2.5 g/l (l-aspartic acid)     cysteine 0.42 g/l (l-cysteine) glutamic acid 4.2 g/l (l-glutamic acid)     glycine 5.9 g/l (as aminoacetic acid)       histidine 5.1 g/l (l-histidine)       isoleucine 4.2 g/l (l-isoleucine)       leucine 5.9 g/l (l-leucine)       lysine acetate 6.8 g/l equivalent to -lysine 6.8 g/l     methionine 4.2 g/l (l-methionine)     phenylalanine 5.9 g/l (l-phenylalanine)       proline 5.1 g/l (l-proline)   serine 3.4 g/l (l-serine)         threonine 4.2 g/l (l-threonine)       tryptophan 1.4 g/l (l-tryptophan)   tyrosine 0.17 g/l (l-tyrosine) valine 5.5 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with moderately increased requirements who are unable to receive sufficient amounts of protein enterally

Vamin 18 without electrolytes Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

vamin 18 without electrolytes

fresenius kabi new zealand limited - alanine 16 g/l;  ;  ;  ; arginine 11.3 g/l (l-arginine);  ;  ; aspartic acid 3.4 g/l (l-aspartic acid);  ;  ; cysteine 560 mg/l (l-cysteine); glutamic acid 5.6 g/l (l-glutamic acid);  ;  ; glycine 7.9 g/l (as aminoacetic acid);  ;  ;  ; histidine 6.8 g/l (l-histidine);  ;  ;  ; isoleucine 5.6 g/l (l-isoleucine);  ;  ;  ; leucine 7.9 g/l (l-leucine);  ;  ;  ; lysine acetate 12.7 g/l equivalent to 6 g/l lysine a;  ;  ; methionine 5.6 g/l (l-methionine);  ;  ; phenylalanine 7.9 g/l (l-phenylalanine);  ;  ;  ; proline 6.8 g/l (l-proline);  ; serine 4.5 g/l (l-serine);  ;  ;  ;  ; threonine 5.6 g/l (l-threonine);  ;  ;  ; tryptophan 1.9 g/l (l-tryptophan);  ; tyrosine 230 mg/l (l-tyrosine); valine 7.3 g/l (l-valine);  ;  ;   - solution for infusion - active: alanine 16 g/l       arginine 11.3 g/l (l-arginine)     aspartic acid 3.4 g/l (l-aspartic acid)     cysteine 560 mg/l (l-cysteine) glutamic acid 5.6 g/l (l-glutamic acid)     glycine 7.9 g/l (as aminoacetic acid)       histidine 6.8 g/l (l-histidine)       isoleucine 5.6 g/l (l-isoleucine)       leucine 7.9 g/l (l-leucine)       lysine acetate 12.7 g/l equivalent to 6 g/l lysine a     methionine 5.6 g/l (l-methionine)     phenylalanine 7.9 g/l (l-phenylalanine)       proline 6.8 g/l (l-proline)   serine 4.5 g/l (l-serine)         threonine 5.6 g/l (l-threonine)       tryptophan 1.9 g/l (l-tryptophan)   tyrosine 230 mg/l (l-tyrosine) valine 7.3 g/l (l-valine)       excipient: glacial acetic acid water for injection - intravenous supply of amino acids to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is need to control the total amount of fluid being given to a patient. vamin 18 has been shown to reduce nitrogen loss in patients with major burns without sepsis.

Tranexamic-AFT tranexamic acid 500 mg/5 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

tranexamic-aft tranexamic acid 500 mg/5 ml solution for injection ampoule

aft pharmaceuticals pty ltd - tranexamic acid, quantity: 100 mg/ml - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.